Integration of Tumor-Infiltrating Lymphocytes, PD-L1, CD8, and FOXP3 in Prognostic Models for Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Integration of Tumour Infiltrating Lymphocytes, Programmed Cell-Death Ligand-1, CD8 and FOXP3 in Prognostic Models for Triple-Negative Breast Cancer: Analysis of 244 Stage I-III Patients Treated With Standard Therapy
Eur. J. Cancer 2020 Sep 01;136(136)7-15, MV Dieci, V Tsvetkova, G Griguolo, F Miglietta, G Tasca, CA Giorgi, E Cumerlato, D Massa, M Lo Mele, E Orvieto, V Guarneri, P ConteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.